Minneapolis Clinical Trials

2030 Study (Hepatic)

To evaluate the safety and tolerability of an investigational medication in volunteers with moderate and severe liver impairment compared to those with normal liver function

8 nights
2 visits

The purpose: to evaluate the safety and tolerability of an investigational medication in volunteers with moderate and severe liver impairment compared to those with normal liver function.

Reimbursement for study participation will be provided for time and travel of up to $2,750.

Call Jenna at 651-724-0500 to discuss your eligibility.

Free transportation can be arranged for some visits.

This study has been approved by an independent ethics committee.

Eligibility

Biological Sex Male or Female
Age 18-75 years old
BMI 18 to 38
Medications Maybe taking medications such as lasix, lactulose, rifaximin, and spironolactone